Spectral Medical Inc.
EDTXFOTCHealthcare● Active
$1.01
$-0.01(-0.98%)
Market Cap$278861000
P/E Ratio—
52W High$1.311
52W Low$0.58
Spectral Medical Inc. (EDTXF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
EDTXF · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 8, 2026EPS Actual
-$0.01
Est. -$0.01 · -39.1%
Revenue
$0.00B
Est. $0.00B · +18.2%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 8, 2026
After Market Close
▼ Miss EPS▲ Beat Revenue
EDTXF reports quarterly as a OTC-listed Medical - Diagnostics & Research company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.01B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.01B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 7, 2026 | -$0.01 | — | — | — | $0.00B | — |
| ▼ Q2 FY2026 | May 8, 2026 | -$0.01 | -$0.01 | -39.1% | $0.00B | $0.00B | +18.2% |
| ▼ Q1 FY2026 | Mar 26, 2026 | -$0.01 | -$0.01 | -37.4% | $0.00B | $0.00B | -29.4% |
| ▼ Q4 FY2025 | Nov 7, 2025 | -$0.01 | -$0.08 | -1014.2% | $0.00B | $0.00B | -10.5% |
| — Q3 FY2025 | Aug 8, 2025 | — | -$0.00 | — | $0.00B | — | — |
| — Q2 FY2025 | May 9, 2025 | — | -$0.03 | — | $0.00B | — | — |
| — Q1 FY2025 | Mar 26, 2025 | — | $0.01 | — | $0.00B | — | — |
| — Q4 FY2024 | Nov 8, 2024 | — | -$0.03 | — | $0.00B | — | — |
Q3 FY2026
Aug 7, 2026
EPS Actual
—
EPS Est.
-$0.01
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 8, 2026Miss
EPS Actual
-$0.01
EPS Est.
-$0.01
EPS Surpr.
-39.1%
Revenue
$0.00B
Q1 FY2026
Mar 26, 2026Miss
EPS Actual
-$0.01
EPS Est.
-$0.01
EPS Surpr.
-37.4%
Revenue
$0.00B
Q4 FY2025
Nov 7, 2025Miss
EPS Actual
-$0.08
EPS Est.
-$0.01
EPS Surpr.
-1014.2%
Revenue
$0.00B
Q3 FY2025
Aug 8, 2025
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2025
May 9, 2025
EPS Actual
-$0.03
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2025
Mar 26, 2025
EPS Actual
$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2024
Nov 8, 2024
EPS Actual
-$0.03
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $-0.01 | $-0.01 | $-0.01 | 1 |
| Q3 FY2026 | $-0.01 | $-0.01 | $-0.01 | 1 |
| Q2 FY2026 | $-0.01 | $-0.01 | $-0.01 | 1 |
| Q1 FY2026 | $-0.01 | $-0.01 | $-0.01 | 1 |
| Q4 FY2025 | $-0.01 | $-0.01 | $-0.01 | 1 |
| Q3 FY2025 | $-0.01 | $-0.01 | $-0.01 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 8, 2026 | -39.1% | $1.02 | $1.03 | +0.98% |
| ▼ Q1 FY2026 | Mar 26, 2026 | -37.4% | $1.06 | $1.08 | +1.89% |
| ▼ Q4 FY2025 | Nov 7, 2025 | -1014.2% | $1.02 | $1.02 | +0.00% |
| — Q3 FY2025 | Aug 8, 2025 | — | $0.61 | $0.59 | -2.50% |
| — Q2 FY2025 | May 9, 2025 | — | $0.62 | $0.62 | +0.38% |
| — Q1 FY2025 | Mar 26, 2025 | — | $0.52 | $0.52 | +1.82% |
| — Q4 FY2024 | Nov 8, 2024 | — | $0.40 | $0.41 | +1.71% |
| — Q3 FY2024 | Aug 9, 2024 | — | $0.41 | $0.43 | +4.51% |
Q2 FY2026+0.98%
Report Date
May 8, 2026
EPS Beat/Miss
-39.1%
Price Before
$1.02
Price After
$1.03
Q1 FY2026+1.89%
Report Date
Mar 26, 2026
EPS Beat/Miss
-37.4%
Price Before
$1.06
Price After
$1.08
Q4 FY2025+0.00%
Report Date
Nov 7, 2025
EPS Beat/Miss
-1014.2%
Price Before
$1.02
Price After
$1.02
Q3 FY2025-2.50%
Report Date
Aug 8, 2025
EPS Beat/Miss
—
Price Before
$0.61
Price After
$0.59
Q2 FY2025+0.38%
Report Date
May 9, 2025
EPS Beat/Miss
—
Price Before
$0.62
Price After
$0.62
Q1 FY2025+1.82%
Report Date
Mar 26, 2025
EPS Beat/Miss
—
Price Before
$0.52
Price After
$0.52
Q4 FY2024+1.71%
Report Date
Nov 8, 2024
EPS Beat/Miss
—
Price Before
$0.40
Price After
$0.41
Q3 FY2024+4.51%
Report Date
Aug 9, 2024
EPS Beat/Miss
—
Price Before
$0.41
Price After
$0.43
Avg Miss Reaction+0.96%
Beat Rate0 / 8 quarters
Largest Move+4.51% (Q3 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: EDTXF ends December
Spectral Medical Inc. (EDTXF) most recently reported earnings on May 8, 2026 for Q2 FY2026, posting EPS of $-0.01 — missing the analyst consensus of $-0.01 by -39.1%. The next EDTXF earnings date is expected around September 1, 2026.
Each quarter, investors track EDTXF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. EDTXF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
EDTXF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
EDTXF earnings · 5 questionsSpectral Medical Inc.'s next earnings report is expected around September 1, 2026. EDTXF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; EDTXF historically reports after market close (AMC).
EDTXF earnings datewhen is EDTXF earningsEDTXF next earnings datewhen does EDTXF report earningsEDTXF earnings calendar
▸ Source: FMP · Spectral Medical Inc. SEC filings · US GAAP · Spectral Medical Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026